Suchergebnisse - "Zhu, Hanzhang"

PubPharm (24)

11

Nanomedicine-mediated induction of immunogenic cell death and prevention of PD-L1 overexpression for enhanced hepatocellular carcinoma therapy

enthalten in: Cancer nanotechnology | 2020

von Zhu, H. | Zhou, W. | Wan, Y. | +3

12

Nanomedicine-mediated induction of immunogenic cell death and prevention of PD-L1 overexpression for enhanced hepatocellular carcinoma therapy

enthalten in: Cancer nanotechnology | 2020

von Zhu, H. | Zhou, W. | Wan, Y. | +3

13

LncRNA CYTOR promotes pancreatic cancer cell proliferation and migration by sponging miR-205-5p

enthalten in: Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al. | 2020

von Zhu, H. | Shan, Y. | Ge, K. | +3

14

Oxaliplatin induces immunogenic cell death in hepatocellular carcinoma cells and synergizes with immune checkpoint blockade therapy

enthalten in: Cellular oncology | 2020

von Zhu, H. | Shan, Y. | Ge, K. | +3

15

Oxaliplatin induces immunogenic cell death in hepatocellular carcinoma cells and synergizes with immune checkpoint blockade therapy

enthalten in: Cellular oncology | 2020

von Zhu, H. | Shan, Y. | Ge, K. | +3

16

Oxaliplatin induces immunogenic cell death in hepatocellular carcinoma cells and synergizes with immune checkpoint blockade therapy

enthalten in: Cellular oncology | 2020

von Zhu, H. | Shan, Y. | Ge, K. | +3

17

Downregulation of GNAI3 Promotes the Pathogenesis of Methionine/Choline-Deficient Diet-Induced Nonalcoholic Fatty Liver Disease

enthalten in: Gut and liver | 2020

von Zhu, H. | Ge, K. | Lu, J. | +1

18

Specific Overexpression of Mitofusin-2 in Hepatic Stellate Cells Ameliorates Liver Fibrosis in Mice Model

enthalten in: Human gene therapy | 2020

von Zhu, H. | Shan, Y. | Ge, K. | +3

19

Growth inhibitor of human hepatic carcinoma HepG2 cells by evodiamine is associated with downregulation of PRAME

enthalten in: Naunyn-Schmiedeberg's archives of pharmacology | 2019

von Zhu, H. | Ge, K. | Lu, J. | +1

20

Growth inhibitor of human hepatic carcinoma HepG2 cells by evodiamine is associated with downregulation of PRAME

enthalten in: Naunyn-Schmiedeberg's archives of pharmacology | 2019

von Zhu, H. | Ge, K. | Lu, J. | +1